BioSpace News Archive

PlaqueTec Announces First Peer-Reviewed Publication for its Liquid Biopsy System (LBS)

PlaqueTec today announced the publication of the first peer-reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System to detect biomarkers for coronary artery disease.

January 3, 2018
·
5 min read
Biotech Beach

PROCEPT BioRobotics Completes Enrollment in WATER II Pivotal Clinical Trial

The WATER II Study is a U.S. investigational device exemption (IDE) clinical trial evaluating the safety and efficacy of Aquablation therapy.

January 3, 2018
·
4 min read
Business

Alligator Bioscience to Receive USD 6 Million Milestone Payment From Janssen Coupled to the Decision to Initiate Combination Trial With ADC-1013

This is the first out of a number of pre-defined milestones, related to the start of combination or phase II studies as part of the ADC-1013 clinical program.

January 3, 2018
·
3 min read
Policy

Asana BioSciences Announces Acceptance of IND Application for Its Oral ERK1/2 Inhibitor

Asana BioSciences announced that the U.S. FDA has accepted the IND application for ASN007, a potent and selective ERK1/2 inhibitor.

January 3, 2018
·
3 min read
BioCapital

CEL-SCI Issues Letter to Shareholders

CEL-SCI enters 2018 in a position of strength and hope for the year ahead.

January 3, 2018
·
8 min read
Intec Pharma Granted Patent in Canada for Accordion Pill Carbidopa / Levodopa

Intec Pharma today announced that the Canadian Intellectual Property Office has issued a Certificate of Grant of a Canadian patent No. 2,721,493.

January 3, 2018
·
4 min read
Biotech Beach

OncoSec Provides 2018 Business Outlook

OncoSec Medical announced its anticipated operational milestones for 2018 and a review of business highlights for year-end 2017.

January 3, 2018
·
12 min read
Business

Eiger BioPharma Appoints David Apelian, MD, PhD, MBA COO and Executive Medical Officer

Dr. Apelian was most recently Executive VP and CMO of Achillion, a position he held since 2013.

January 3, 2018
·
4 min read
Business

Axcella Announces Appointment of David Epstein, Former CEO of Novartis Pharmaceuticals, as Chairman of its Board of Directors

Mr. Epstein is an Executive Partner at Flagship Pioneering.

January 3, 2018
·
3 min read
Seegene Develops World’s First Multiplex MDx Assays With its AI System

Seegene announced today that, utilizing a newly created AI based assay development system, the company succeeded in developing MDx assays in only four days.

January 3, 2018
·
2 min read